Research
Medicinal Cannabis—Potential Drug Interactions
Original article found here Muhammad A. Alsherbiny 1,2,* and Chun Guang Li 1,* 1 NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia
cannabinoid
Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.
Abstract ∆9-Tetrahydrocannabinol (THC) is one of the major bioactive cannabinoids derived from the Cannabis sativa plant and is known for
Peripherally Restricted Cannabinoids for the Treatment of Pain.
Authors: Romero-Sandoval EA, Asbill S, Paige CA, Byrd-Glover K. Abstract The use of cannabinoids for the treatment of chronic diseases has
Cannabinoids in the management of chronic pain: a front line clinical perspective.
Author: Mary E. Lynch Abstract Chronic pain is an escalating public health problem. Currently available treatments are inadequate to control chronic
